Mark Coleman insider trades: Axsome Therapeutics (AXSM) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mark reports to the SEC
Open-market buys and sales
15 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | AXSM | ↓ Sell | 643 | $249.00 | $160K | Direct | Jun 10, 2026 (0d) |
| Jun 2, 2026 | AXSM | ↓ Sell | 17,537 | $229.20 | $4.0M | Direct | Jun 2, 2026 (0d) |
| Feb 26, 2026 | AXSM | ↓ Sell | 25,000 | $161.11 | $4.0M | Direct | Feb 27, 2026 (1d) |
| Sep 8, 2025 | AXSM | ↑ Buy | 1,575 | $127.28 | $200K | Direct | Sep 9, 2025 (1d) |
| May 28, 2025 | AXSM | ↓ Sell | 7,500 | $104.45 | $783K | Direct | May 29, 2025 (1d) |
| May 20, 2025 | AXSM | ↓ Sell | 3,000 | $107.49 | $322K | Direct | May 20, 2025 (0d) |
| May 29, 2024 | AXSM | ↓ Sell | 10,497 | $75.17 | $789K | Direct | May 29, 2024 (0d) |
| Sep 15, 2023 | AXSM | ↓ Sell | 18,572 | $75.18 | $1.4M | Indirect | Sep 15, 2023 (0d) |
| Sep 15, 2023 | AXSM | ↓ Sell | 11,016 | $75.19 | $828K | Direct | Sep 15, 2023 (0d) |
| Nov 18, 2021 | AXSM | ↑ Buy | 1,430 | $35.09 | $50K | Indirect | Nov 22, 2021 (4d) |
| May 12, 2021 | AXSM | ↑ Buy | 500 | $58.15 | $29K | Indirect | May 13, 2021 (1d) |
| Jun 29, 2020 | AXSM | ↑ Buy | 650 | $78.50 | $51K | Direct | Jun 30, 2020 (1d) |
| Jun 26, 2019 | AXSM | ↑ Buy | 16,200 | $23.10 | $374K | Direct | Jun 27, 2019 (1d) |
| May 13, 2019 | AXSM | ↑ Buy | 4,650 | $21.44 | $100K | Direct | May 15, 2019 (2d) |
| Mar 19, 2019 | AXSM | ↑ Buy | 5,100 | $12.18 | $62K | Indirect | Mar 21, 2019 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other AXSM insiders
Open-market trades in the last 12 months
About Mark Coleman's insider trades
Mark Coleman is an insider at Axsome Therapeutics (AXSM). Since Mar 19, 2019, Mark has reported 7 open-market purchases worth $867K and 8 sales worth $12.3M on SEC Form 4. In the last 12 months: 3 sales ($8.2M).
Their filings also include grants and awards (19 filings), option exercises (8 filings), gifts (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AXSM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.